Product Images Droxidopa

This data presents the baseline value of 5.1 and the units in both groups. The focus is on the drug Droxidopa and the mean change in dizziness which is -3.5. The treatment phase lasts for 8 weeks, with the first 4 weeks being the double-blind phase.*

This is a prescription drug. The name of the drug is Droxidopa Capsules, and the manufacturer is Aurobindo Pharma USA, Inc. Each bottle contains 90 capsules, and each capsule has 100mg Droxidopa. The usual dosage is specified in the prescribing information. It should be stored at a temperature between 20°C to 25°C and dispensed in a tightly closed container. A warning has been given to keep it out of the reach of children. The drug is made in India. There is additional text regarding the printing zone and a coding area.*

Droxidopa Capsules are available in a 90-capsule container, with each capsule containing 200 mg of droxidopa. It is recommended to see prescribing information for the usual dosage. The medication must be stored in a tight, light-resistant container at a controlled room temperature. The manufacturer warns not to use if the printed seal under the cap is broken or missing and to keep the medication out of reach of children. The product is distributed by Aurobindo Pharma USA, Inc. and made in India. There is an overprinting zone and coding area on the packaging.*

Droxidopa capsules contain 300mg per capsule and are available in a bottle of 90 capsules. The capsules should be stored in a tight, light-resistant container at 20° to 25°C (68° to 77°F). Keep out of reach of children, and do not use if the printed seal under the cap is broken or missing. Usual dosage instructions can be found in the prescribing information. Distributed by Aurobindo Pharma USA and made in India.*